Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
Regeneron recognizes new combos to boost I-O drug Libtayo's cancer responsePD-1/L1 inhibitors work by enhancing the immune response to cancer, have benefitted patients combat several types of ...
AbbVie, Sofinnova back USD 38 Million for Nitrome BiosciencesNitrome Biosciences contemplates treating Parkinson's disease and diabetes by targeting a new class of enzymes. The pharma raised U...
A Philadelphia-based pharmaceutical, Annovis Bio, has raised USD12 million by listing its 2 million shares at USD 6 each.The company has managed to net USD 2 million more by offering 40% more...
The drug, sotatercept of Acceleron Pharma, touches the phase 2 markAcceleron Pharma, a clinical-stage biopharmaceutical company based in Boston, Massachusetts with a primary aim on the develop...
Progress is driven by innovation. When it comes to developing novel medications and the...
The HIV-1 treatment market for naïve and experienced patients is evolving consistently....
The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...
Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...
Advances in genetics research have sparked a surge in interest in gene therapy in derma...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
